64 related articles for article (PubMed ID: 8713101)
21. Synthesis, biological activity and isomerism of guanylate cyclase C-activating peptides guanylin and uroguanylin.
Klodt J; Kuhn M; Marx UC; Martin S; Rösch P; Forssmann WG; Adermann K
J Pept Res; 1997 Sep; 50(3):222-30. PubMed ID: 9309586
[TBL] [Abstract][Full Text] [Related]
22. Cloning and mRNA expression of guanylin, uroguanylin, and guanylyl cyclase C in the Spinifex hopping mouse, Notomys alexis.
Donald JA; Bartolo RC
Gen Comp Endocrinol; 2003 Jun; 132(1):171-9. PubMed ID: 12765657
[TBL] [Abstract][Full Text] [Related]
23. Computational analyses and prediction of guanylin deleterious SNPs.
Porto WF; Franco OL; Alencar SA
Peptides; 2015 Jul; 69():92-102. PubMed ID: 25899674
[TBL] [Abstract][Full Text] [Related]
24. Purification, cDNA sequence, and tissue distribution of rat uroguanylin.
Li Z; Perkins AG; Peters MF; Campa MJ; Goy MF
Regul Pept; 1997 Jan; 68(1):45-56. PubMed ID: 9094754
[TBL] [Abstract][Full Text] [Related]
25. A new human guanylate cyclase-activating peptide (GCAP-II, uroguanylin): precursor cDNA and colonic expression.
Hill O; Cetin Y; Cieslak A; Mägert HJ; Forssmann WG
Biochim Biophys Acta; 1995 Dec; 1253(2):146-9. PubMed ID: 8519795
[TBL] [Abstract][Full Text] [Related]
26. Rat guanylin cDNA: characterization of the precursor of an endogenous activator of intestinal guanylate cyclase.
Wiegand RC; Kato J; Currie MG
Biochem Biophys Res Commun; 1992 Jun; 185(3):812-7. PubMed ID: 1378267
[TBL] [Abstract][Full Text] [Related]
27. Precursor structure, expression, and tissue distribution of human guanylin.
de Sauvage FJ; Keshav S; Kuang WJ; Gillett N; Henzel W; Goeddel DV
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9089-93. PubMed ID: 1409606
[TBL] [Abstract][Full Text] [Related]
28. Molecular biology of the peptide hormone families.
Pearson RK; Anderson B; Dixon JE
Endocrinol Metab Clin North Am; 1993 Dec; 22(4):753-74. PubMed ID: 7907289
[TBL] [Abstract][Full Text] [Related]
29. Coordinate upregulation of guanylin and uroguanylin expression by hypertonicity in HT29-18-N2 cells.
Steinbrecher KA; Rudolph JA; Luo G; Cohen MB
Am J Physiol Cell Physiol; 2002 Dec; 283(6):C1729-37. PubMed ID: 12388101
[TBL] [Abstract][Full Text] [Related]
30. Enterochromaffin cells of the digestive system: cellular source of guanylin, a guanylate cyclase-activating peptide.
Cetin Y; Kuhn M; Kulaksiz H; Adermann K; Bargsten G; Grube D; Forssmann WG
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):2935-9. PubMed ID: 8159683
[TBL] [Abstract][Full Text] [Related]
31. The circulating bioactive form of human guanylin is a high molecular weight peptide (10.3 kDa).
Kuhn M; Raida M; Adermann K; Schulz-Knappe P; Gerzer R; Heim JM; Forssmann WG
FEBS Lett; 1993 Mar; 318(2):205-9. PubMed ID: 8095028
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the human guanylin gene and the processing and cellular localization of the peptide.
Hill O; Kuhn M; Zucht HD; Cetin Y; Kulaksiz H; Adermann K; Klock G; Rechkemmer G; Forssmann WG; Mägert HJ
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2046-50. PubMed ID: 7892222
[TBL] [Abstract][Full Text] [Related]
33. Promoter analysis of a medaka fish intestinal guanylyl cyclase gene.
Nakauchi M; Suzuki N
FEBS Lett; 2003 Feb; 536(1-3):12-8. PubMed ID: 12586330
[TBL] [Abstract][Full Text] [Related]
34. Carboxy-terminal extension stabilizes the topological stereoisomers of guanylin.
Schulz A; Escher S; Marx UC; Meyer M; Rösch P; Forssmann WG; Adermann K
J Pept Res; 1998 Dec; 52(6):518-25. PubMed ID: 9924996
[TBL] [Abstract][Full Text] [Related]
35. Regulation of intestinal gene expression by dietary zinc: induction of uroguanylin mRNA by zinc deficiency.
Blanchard RK; Cousins RJ
J Nutr; 2000 May; 130(5S Suppl):1393S-8S. PubMed ID: 10801950
[TBL] [Abstract][Full Text] [Related]
36. [Guanylin family, a new gastrointestinal peptide acting on the control of water-NaCl metabolism].
Nakazato M; Matsukura S
Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):741-6. PubMed ID: 9627486
[No Abstract] [Full Text] [Related]
37. Guanylin bioactivity in human intestinal and opossum kidney cells.
Forte LR; Krause WJ; Freeman RH
Adv Second Messenger Phosphoprotein Res; 1993; 28():133-8. PubMed ID: 8398394
[No Abstract] [Full Text] [Related]
38. Circulating and tissue guanylin immunoreactivity in intestinal secretory diarrhoea.
Kuhn M; Kulaksiz H; Cetin Y; Frank M; Nold R; Arnold R; Böker K; Bischoff SC; Manns MP; Forssmann WG
Eur J Clin Invest; 1995 Dec; 25(12):899-905. PubMed ID: 8719928
[TBL] [Abstract][Full Text] [Related]
39. Theoretical structural characterization of lymphoguanylin: A potential candidate for the development of drugs to treat gastrointestinal disorders.
Pires ÁS; Porto WF; Castro PO; Franco OL; Alencar SA
J Theor Biol; 2017 Apr; 419():193-200. PubMed ID: 28214543
[TBL] [Abstract][Full Text] [Related]
40. Structural impact analysis of missense SNPs present in the uroguanylin gene by long-term molecular dynamics simulations.
Marcolino AC; Porto WF; Pires ÁS; Franco OL; Alencar SA
J Theor Biol; 2016 Dec; 410():9-17. PubMed ID: 27620667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
